Achieve Life Sciences ACHV Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Achieve Life Sciences’s reported figures.
Based on trailing twelve months.
The official record: Achieve Life Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Achieve Life Sciences's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Achieve Life Sciences's return on equity?
- Achieve Life Sciences (ACHV) reported return on equity of -496.1% in Q1 2026.
- How has Achieve Life Sciences's return on equity changed year-over-year?
- Achieve Life Sciences's return on equity decreased by 221.0% year-over-year, from -154.5% to -496.1%.
- What is the long-term trend for Achieve Life Sciences's return on equity?
- Over 3 years (2020 to 2025), Achieve Life Sciences's return on equity has grown at a 69.2% compound annual growth rate (CAGR), from -53.2% to -257.7%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.